Compare VREX & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VREX | XOMA |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 501.8M | 471.6M |
| IPO Year | 2016 | N/A |
| Metric | VREX | XOMA |
|---|---|---|
| Price | $9.80 | $41.79 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | $16.67 | ★ $52.50 |
| AVG Volume (30 Days) | 242.0K | ★ 387.1K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $811,000,000.00 | N/A |
| Revenue This Year | $5.35 | $24.59 |
| Revenue Next Year | $3.88 | N/A |
| P/E Ratio | $238.60 | ★ $29.64 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.76 | $22.29 |
| 52 Week High | $14.57 | $42.81 |
| Indicator | VREX | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 32.50 | 70.52 |
| Support Level | $6.76 | $24.38 |
| Resistance Level | $12.44 | $42.81 |
| Average True Range (ATR) | 0.69 | 1.10 |
| MACD | -0.15 | -0.25 |
| Stochastic Oscillator | 16.17 | 83.65 |
Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates. The Company's drug royalty aggregator business is mainly focused on the acquisition of early to mid-stage clinical assets. Geographically, the company operates in Switzerland, the United States, Asia Pacific, Europe, and other regions.